Locations:
Searchimages: 0
video: 0
audio: 0
text: 0
LONDON: Cleveland Clinic London is now offering patients access to donanemab, a newly approved Alzheimer’s therapy shown to slow the progression of the disease. This follows the introduction of lecanemab in 2024, further expanding access to innovative treatment options for eligible patients.
Both therapies represent the first disease-modifying treatments for Alzheimer’s available in the UK in over two decades – offering renewed hope for adults with mild cognitive impairment or mild dementia due to Alzheimer’s.
Cleveland Clinic has played a key role in the global research and development of Alzheimer's therapies, contributing to phase 3 clinical trial of lecanemab and advancing the diagnostic approaches such as biomarker-based detection, including amyloid PET imaging to confirm eligibility.
These offerings build on Cleveland Clinic London’s commitment to innovative, patient-centred neurological care – delivering access to transformative treatments for those affected by Alzheimer’s.
The multi-disciplinary model of care and specialised outpatient services Cleveland Clinic London offers makes it uniquely positioned to provide these therapies through coordinated support across neurology, imaging and clinical teams.
Cleveland Clinic is a nonprofit multispecialty academic medical centre that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 82,600 employees worldwide are more than 5,786 salaried physicians and researchers, and 20,700 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,728-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 280 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2024, there were 15.7 million outpatient encounters, 333,000 hospital admissions and observations, and 320,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 112 countries. Visit us at clevelandclinic.org. Follow us at x.com/CleClinicNews. News and resources are available at newsroom.clevelandclinic.org.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
Cleveland Clinic London is the latest location in Cleveland Clinic’s expanding global footprint, allowing Cleveland Clinic to extend its model of care to more patients than ever. Cleveland Clinic London hospital opened on March 29, 2022. It has 184 inpatient beds, including 29 ICU beds; eight operating rooms; a full imaging suite; endoscopy and cardiac catheterization laboratories; day case rooms for surgery; and a state-of-the-art rehabilitation unit focusing on neurological rehabilitation and brain injury. In addition to comprehensive cardiovascular and thoracic services, it offers orthopedics, digestive diseases, urology, neurosciences, ear, nose and throat, general surgery, general practice, and executive health. Cleveland Clinic London consists of a hospital and an outpatient center. Cleveland Clinic Portland Place Outpatient Centre, a six-story, 28,000-square foot building at Portland Place, in the Harley Street Health District; and Cleveland Clinic Moorgate Outpatient Centre in the City of London. Visit us at clevelandcliniclondon.uk/. Follow us at twitter.com/clecliniclondon. News and resources available at newsroom.clevelandclinic.org/tag/london.
